ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Histone Deacetylase Inhibitors: Current Status in Treatment of Leukemia

Journal: Current Research in Pharmaceutical Sciences (Vol.3, No. 4)

Publication Date:

Authors : ; ; ; ; ; ; ;

Page : 102-107

Keywords : ;

Source : Downloadexternal Find it from : Google Scholarexternal


Leukemia, one of leading cancer occurs by the acquisition of gene mutations that confer deregulated proliferation and impaired differentiation. Several histone decaetylase inhibitors (HDACi) have exhibited significant protection against the growth of tumor cells in vitro as well as in vivo. Thus it is anticipated that some HDACi could be efficient anti-leukemic drugs. Here, we summarize the current status of different types of HDACi and their clinical role in therapy of different types of leukemia.

Last modified: 2017-06-06 15:50:39